These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 142419

  • 1. Role of dopaminergic receptors in the regulation of growth hormone secretion.
    Müller EE, Liuzzi A, Cocchi D, Panerai AE, Oppizzi G, Lacatelli V, Mantegazza P, Silvestrini F, Chiodini PG.
    Adv Biochem Psychopharmacol; 1977; 16():127-38. PubMed ID: 142419
    [No Abstract] [Full Text] [Related]

  • 2. [Huntington's chorea and somatotropic hormone: dynamic explorations in 27 cases (author's transl)].
    Destée A, Petit H, Fossati P, Warot P.
    Rev Neurol (Paris); 1981; 137(1):21-31. PubMed ID: 6453416
    [No Abstract] [Full Text] [Related]

  • 3. Neuroendocrine aspects in monitoring of dopaminergic drugs in man.
    Hietala J, Koulu M, Scheinin M, Syvälahti E.
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):451-4. PubMed ID: 3935892
    [Abstract] [Full Text] [Related]

  • 4. [Significance of blood levels of prolactin and somatotropin as indices of pharmacological effects on the central nervous system].
    Barreca T, Gallamini A, Murialdo G, Nizzo MC, Polleri A.
    Clin Ter; 1978 Jul 31; 86(2):147-59. PubMed ID: 743856
    [No Abstract] [Full Text] [Related]

  • 5. Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.
    Chalmers RJ, Johnson RH, Keogh HJ, Nanda RN.
    J Neurol Neurosurg Psychiatry; 1978 Feb 31; 41(2):135-9. PubMed ID: 24678
    [Abstract] [Full Text] [Related]

  • 6. Neuropharmacological intervention on the pituitary-hypothalamic relationship.
    Tuomisto J.
    Ann Clin Res; 1978 Feb 31; 10(3):120-32. PubMed ID: 31130
    [No Abstract] [Full Text] [Related]

  • 7. [The effect of dopaminergic block on secretion of the growth hormone (author's transl)].
    Hainer V, Krejcík L, Urbánek J, Malec J.
    Cas Lek Cesk; 1978 May 12; 117(19):590-2. PubMed ID: 679233
    [No Abstract] [Full Text] [Related]

  • 8. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan 12; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine.
    Fuxe K, Fredholm BB, Ogren SO, Agnati LF, Hökfelt T, Gustafsson JA.
    Acta Endocrinol Suppl (Copenh); 1978 Jan 12; 216():27-56. PubMed ID: 347864
    [No Abstract] [Full Text] [Related]

  • 10. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK, Manzino L, Heikkila RE.
    J Pharmacol Exp Ther; 1988 Oct 12; 247(1):180-5. PubMed ID: 2971797
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone secretion in neurological disorders.
    Martinez-Campos A, Giovannini P, Cocchi D, Zanardi P, Parati EA, Caraceni T, Müller EE.
    Adv Biochem Psychopharmacol; 1981 Oct 12; 28():521-40. PubMed ID: 6452036
    [No Abstract] [Full Text] [Related]

  • 12. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V, Nedvídková J.
    Endokrinologie; 1982 Oct 12; 80(2):201-6. PubMed ID: 6819130
    [No Abstract] [Full Text] [Related]

  • 13. The role of D-1 and D-2 receptors.
    Schachter M, Bédard P, Debono AG, Jenner P, Marsden CD, Price P, Parkes JD, Keenan J, Smith B, Rosenthaler J, Horowski R, Dorow R.
    Nature; 1980 Jul 10; 286(5769):157-9. PubMed ID: 7402308
    [Abstract] [Full Text] [Related]

  • 14. Indirect evidence for a feedback loop mechanism between two central dopaminergic pathways: preliminary results.
    Yehuda S.
    Commun Psychopharmacol; 1979 Jul 10; 3(2):115-9. PubMed ID: 467002
    [No Abstract] [Full Text] [Related]

  • 15. Central dopaminergic excitatory and inhibitory systems in Nelson's syndrome.
    Nishida S, Matsuki M, Horino M, Endoh M, Kakita K, Tenku A, Oyama H.
    Horm Metab Res; 1982 Dec 10; 14(12):681-2. PubMed ID: 7152484
    [No Abstract] [Full Text] [Related]

  • 16. Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea.
    Müller EE, Parati EA, Panerai AE, Cocchi D, Caraceni T.
    Neuroendocrinology; 1979 Dec 10; 28(5):313-9. PubMed ID: 155781
    [Abstract] [Full Text] [Related]

  • 17. Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
    Agnoli A, Ruggieri S, Baldassarre M, Rocco A, Del Roscio S, D'Urso R, Mearelli S, Falaschi P, Frajese G.
    Prog Clin Biol Res; 1980 Dec 10; 39():215-24. PubMed ID: 6773067
    [No Abstract] [Full Text] [Related]

  • 18. A neuroendocrinological investigation of patients with senile demantia of Alzheimer type. Plasma prolactin and GH responses following TRH, sulpiride, L-dopa, and bromocriptine administration.
    Fujita M, Shimizu T.
    Bull Osaka Med Sch; 1986 Oct 10; 32(2):73-84. PubMed ID: 3122863
    [No Abstract] [Full Text] [Related]

  • 19. Effects of dopaminergic receptor stimulation and opioid receptor blockade on GH incretion: preliminary findings.
    Ghisoli E, Benfenati F, Pancaldi L, Meringolo D, Catenacci M.
    Boll Soc Ital Biol Sper; 1980 Jun 30; 56(12):1222-5. PubMed ID: 6257257
    [Abstract] [Full Text] [Related]

  • 20. Similar response to dopaminergic or anti-dopaminergic drugs in acromegaly.
    Tater D, Maudelonde T, Sudre Y, Besson G, Bercovici JP.
    Horm Metab Res; 1984 Feb 30; 16(2):104-5. PubMed ID: 6706287
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.